Drug Research

Our integrated Drug Discovery Services are designed to reduce your costs and timelines, helping you meet your drug discovery milestones. Our innovative scientists have accumulated discovery experience. To fully assist drug discovery, Aqlivia provides unique drug discovery services that span the entire drug discovery continuum and support both target-based and phenotypic discovery.

With well enabled capabilities in Oncology, Metabolic Disorders, Pain, Inflammation, Toxicity and Fibrosis, Aqlivia has rapidly emerged as a leading collaborator for biotechnology and pharmaceutical companies worldwide.

In each of these therapeutic areas, Aqlivia has developed in-depth expertise in drug discovery informatics, medicinal chemistry, structural biology, in vivo and in vitro pharmacology.

We offer drug discovery services including docking molecular, drug target identification, drug discovery screening – small molecule screening, library screening, ion channel screening – fragment based drug design, ligand based drug design, ligand protein binding, protein ligand docking calculation and prediction, drug profiling, lead identification, lead compound identification and lead optimization.